{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:58:53Z","timestamp":1787500733953,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/mt.2014.192","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T07:33:49Z","timestamp":1412062429000},"page":"179-183","source":"Crossref","is-referenced-by-count":27,"title":["Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells"],"prefix":"10.1016","volume":"23","author":[{"given":"Jan J","family":"Melenhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Krance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M","family":"Leen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A John","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.192_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2006.06.8312","article-title":"Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial","volume":"25","author":"Ribera","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2014.192_bib3","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1200\/JCO.2006.07.1225","article-title":"Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data","volume":"24","author":"Saarinen-Pihkala","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2014.192_bib4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-03-007427","article-title":"Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions","volume":"108","author":"Chakraverty","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.192_bib6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation","volume":"304","author":"Weiden","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.192_bib7","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.192_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","article-title":"Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells","volume":"95","author":"Gustafsson","year":"2000","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2014.192_bib11","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1038\/mt.2014.192_bib13","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.192_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJM199409083311017","article-title":"Donor T cells to treat EBV-associated lymphoma","volume":"331","author":"Heslop","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.192_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcyt.2013.11.010","article-title":"The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care","volume":"16","author":"Saglio","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2014.192_bib16","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib17","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/14653249.2011.575356","article-title":"Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation","volume":"13","author":"Hanley","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2014.192_bib19","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V","article-title":"Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides","volume":"30","author":"Kern","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2014.192_bib20","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1158\/1078-0432.CCR-13-0955","article-title":"Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia\u2013implications for immunotherapy","volume":"19","author":"Weber","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2014.192_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":"Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia","volume":"123","author":"Chessells","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2014.192_bib22","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"Melenhorst","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbmt.2010.12.711","article-title":"Alloreactivity across HLA barriers is mediated by both na\u00efve and antigen-experienced T cells","volume":"17","author":"Melenhorst","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/mt.2014.192_bib24","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbmt.2008.10.023","article-title":"Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy","volume":"15","author":"Behrendt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/mt.2014.192_bib26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib27","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.161.5.2365","article-title":"Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA","volume":"161","author":"Fletcher","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/mt.2014.192_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.leu.2402748","article-title":"Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma","volume":"17","author":"Hermouet","year":"2003","journal-title":"Leukemia"},{"key":"10.1038\/mt.2014.192_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","article-title":"Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?","volume":"119","author":"Della Chiesa","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib30","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib31","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2005-05-1897","article-title":"Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia","volume":"107","author":"Savani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib32","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2008-04-151969","article-title":"High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow","volume":"113","author":"Melenhorst","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2014.192_bib33","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.192_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cyto.a.20986","article-title":"Heavy metal contaminants can eliminate quantum dot fluorescence","volume":"79","author":"Zarkowsky","year":"2011","journal-title":"Cytometry A"},{"key":"10.1038\/mt.2014.192_bib35","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(99)01926-1","article-title":"Aplastic anaemia in donor cells 14 years after bone-marrow transplant","volume":"353","author":"Melenhorst","year":"1999","journal-title":"Lancet"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616300235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T18:39:41Z","timestamp":1689532781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616300235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1525001616300235"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.192","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}